Bolt Biotherapeutics, Inc. (BOLT) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.64HealthcareDelayed quote: Oct 6, 2026, 12:46 PM EDT
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
Total return — BOLT vs INM
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.1%/yr)INM -99.9% (-71.7%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT INM
BOLT vs INM: by the numbers
- •INM is the larger company ($7M vs $7M market cap).
- •Both run net losses; INM's is the smaller (-0.61% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | INM |
|---|---|---|
| P/S ratio | 1.49 | 0.00 |
| P/B ratio | 0.55 | 6.80 |
Profitability
| Metric | BOLT | INM |
|---|---|---|
| Gross margin | 80.62% | 14.92% |
| Operating margin | -450.07% | -0.52% |
| Net margin | -611.47% | -0.61% |
| ROE | -227.37% | -1168.44% |
| ROIC | -90.17% | -995.44% |
Growth (annualized)
| Metric | BOLT | INM |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | -71.98% |
Frequently asked
- How have BOLT and INM total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and INM delivered -71.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.